Cara Therapeutics Inc CARA shares are trading lower by $0.83 at $16.66 in Friday's session. One of the top performing biotech stocks in 2017 is under selling pressure after its Q4 EPS miss.
Cara's stock began 2017 at $9.29 and peaked on March 6 at $19.44. Its highest close in 2017 was made on March 3 at $18.04.
After a lower open, it continued in that direction before finding a bottom at $15.58 and has staged a nice rebound. That low comes in under its February 28 low ($15.82), but well above its February 27 low ($15.02).
The quick rebound off the depressed level has taken it to within $0.11 of the bottom of Thursday's range ($16.89), as $16.78 stands as the high for the session.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
